Table 3 Pros and cons of making researchers and the state responsible
From: Who should pay for the continuity of post-trial health care treatments?
Researches and State | |
|---|---|
Pros | Cons |
Inclusion of clinical trials in public health policy | Inconsistent with official procedures to cover drugs with proven evidence |
Prioritize disease research | Could make the cost of clinical trials in the country prohibitive. |
State could impose conditions for the study | May require change in legislation |
Guaranteed completion of the study | |
State could request / obtain best price | |
Greater transparency | |